Key Takeaways
- • General Medicine raised $120 million in Series B funding led by Andreessen Horowitz, bringing total funding to $152 million since its 2023 founding.
- • The round included participation from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health (through Granger Management), and BoxGroup, with a16z partner Vineeta Agarwala, MD, PhD leading the investment.
- • The healthcare marketplace operates a catalog of over 2,900 products and services including medications, labs, telehealth, specialist e-consults, and select in-person visits and procedures.
- • General Medicine launched nationwide in May 2025 and enables customers to search, compare, and purchase care while viewing both insurance and cash prices before making decisions.
Summary
General Medicine, a San Francisco-based healthcare marketplace, secured $120 million in Series B financing, marking a significant milestone for the company's growth trajectory. The round was led by Andreessen Horowitz with Vineeta Agarwala, MD, PhD, a General Partner at the firm, driving the investment decision. The financing round included a notable syndicate of institutional and strategic investors: Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through its subsidiary Granger Management, and BoxGroup.
Founded in 2023 by TJ Parker, Elliot Cohen, and Ashwin Muralidharan, General Medicine launched its nationwide platform in May 2025 and has rapidly scaled its operations. The company operates as a healthcare store where consumers can search, compare, and purchase medical care with transparent pricing for both insured and uninsured patients. The platform provides guidance from licensed clinicians to help patients navigate their options.
The company's catalog encompasses over 2,900 products and services spanning medications, laboratory tests, telehealth consultations, specialist e-consultations, and select in-person visits and procedures. This breadth of offerings positions General Medicine as a comprehensive marketplace addressing healthcare's transparency and consumer-choice gaps. With the Series B funding, the company has now raised $152 million in total capital. General Medicine maintains offices in both San Francisco and Boston.
Founded in 2023 by TJ Parker, Elliot Cohen, and Ashwin Muralidharan, General Medicine launched its nationwide platform in May 2025 and has rapidly scaled its operations. The company operates as a healthcare store where consumers can search, compare, and purchase medical care with transparent pricing for both insured and uninsured patients. The platform provides guidance from licensed clinicians to help patients navigate their options.
The company's catalog encompasses over 2,900 products and services spanning medications, laboratory tests, telehealth consultations, specialist e-consultations, and select in-person visits and procedures. This breadth of offerings positions General Medicine as a comprehensive marketplace addressing healthcare's transparency and consumer-choice gaps. With the Series B funding, the company has now raised $152 million in total capital. General Medicine maintains offices in both San Francisco and Boston.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.